The general side effects as headache, dizziness, constipation, nausea, abdominal pain, asthenia, pruritus, rash and urticaria are observed.
Renal Effects: In most cases, proteinuria decreases or disappears spontaneously on continued therapy, and has not been shown to be predictive of acute or progressive renal disease.
Skeletal muscle effects: Uncomplicated myalgia and myopathy have been reported in rosuvastatin-treated patients.
Liver Effects: A dose-related increase in transaminases has been observed in a small number of patients taking rosuvastatin; the majority of cases were mild, asymptomatic and transient.
View ADR Monitoring Form